#New nanoparticle drug combination for atherosclerosis developed
“#New nanoparticle drug combination for atherosclerosis developed” Antiatherogenic effect of CSNP. Credit: The Korea Advanced Institute of Science and Technology (KAIST) Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation. The CSNP-based combination drug delivery…